These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15113755)

  • 1. Natural killer T cells accelerate atherogenesis in mice.
    Nakai Y; Iwabuchi K; Fujii S; Ishimori N; Dashtsoodol N; Watano K; Mishima T; Iwabuchi C; Tanaka S; Bezbradica JS; Nakayama T; Taniguchi M; Miyake S; Yamamura T; Kitabatake A; Joyce S; Van Kaer L; Onoé K
    Blood; 2004 Oct; 104(7):2051-9. PubMed ID: 15113755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions.
    Aslanian AM; Chapman HA; Charo IF
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):628-32. PubMed ID: 15591216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ox-LDL-induced CD80
    Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
    Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
    Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
    Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
    J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice.
    Major AS; Wilson MT; McCaleb JL; Ru Su Y; Stanic AK; Joyce S; Van Kaer L; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2351-7. PubMed ID: 15472130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation.
    Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
    Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
    J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis.
    Kritikou E; van Duijn J; Nahon JE; van der Heijden T; Bouwman M; Groeneveldt C; Schaftenaar FH; Kröner MJ; Kuiper J; van Puijvelde GHM; Bot I
    Atherosclerosis; 2019 Jan; 280():132-139. PubMed ID: 30513408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.
    VanderLaan PA; Reardon CA; Cabana VG; Wang CR; Getz GS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
    Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L
    Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.
    VanderLaan PA; Reardon CA; Sagiv Y; Blachowicz L; Lukens J; Nissenbaum M; Wang CR; Getz GS
    Am J Pathol; 2007 Mar; 170(3):1100-7. PubMed ID: 17322392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.